V. Busuttil

827 citations
14 papers · 701 indexed · h-index 8

V. Busuttil

13 papers receiving 689 citations

Peers

V. Busuttil
Comparison fields: 5 of 85
  • Dermatology 114
  • Cancer Research 191
  • Endocrinology 55
  • Cell Biology 164
  • Immunology 182
Replace Dan Hao with:
Dan Hao China
Vijay Shreedhar United States
Kris Nys Belgium
Yoshiaki Ichikawa Japan
Patricia Galán‐Malo Spain
Eva Batanero Spain
Shamima Islam Japan
Zhizhong Zheng China
Z Razi-Wolf United States
James S. Whitehead United States
V. Busuttil relative to Dan Hao China Dan Hao's profile →
Citations per field
00.5×6.1×
Dan Hao · 1×
Citations per year

Countries citing papers authored by V. Busuttil

Since Specialization
Citations

This map shows the geographic impact of V. Busuttil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Busuttil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Busuttil more than expected).

Fields of papers citing papers by V. Busuttil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Busuttil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Busuttil. The network helps show where V. Busuttil may publish in the future.

Co-authorship network

The 25 scholars most cited alongside V. Busuttil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with V. Busuttil Line = papers co-authored together V. Busuttil links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1 20193
2 201820
3 2018192
4 20162
5 20162
6 20154
7 20153
8 201054
9 200462
10 200249
11 200284
12 2001109
13
Activation of nuclear factor kappaB through the IKK complex by the topoisomerase poisons SN38 and doxorubicin: a brake to apoptosis in HeLa human carcinoma cells.
2001117
14
Note on a probable case of toxocara choroiditis
19720

About V. Busuttil

V. Busuttil is a scholar working on Dermatology, Cancer Research and Toxicology, having authored 14 papers that have together received 701 indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (5 papers), Skin Protection and Aging (4 papers), Immune Response and Inflammation (2 papers), melanin and skin pigmentation (2 papers), Cancer therapeutics and mechanisms (1 paper), Bioactive Compounds and Antitumor Agents (1 paper), Cell death mechanisms and regulation (1 paper) and Immunotoxicology and immune responses (1 paper). The work is most often cited by research in Dermatology (114 citations), Cancer Research (191 citations) and Endocrinology (55 citations). V. Busuttil has collaborated with scholars based in France, United States and Italy. Frequent co-authors include J. Botto, C. Serre, Jean‐François Peyron, Véronique Imbert, Virginie Bottero, Robert T. Abraham, Antonia Livolsi, G. Milano, Agnès Loubat and Nicolas Magné. Their work appears in journals such as International Journal of Cosmetic Science, Journal of Investigative Dermatology, European Journal of Biochemistry, Journal of Cosmetic Dermatology and Infection and Immunity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026